Literature DB >> 24839482

Clinical outcome data for off-label medications: The more the better.

Karen Psooy1.   

Abstract

Year:  2014        PMID： 24839482      PMCID： PMC4001634          DOI： 10.5489/cuaj.2058

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  2 in total

1.  Prospective open label study of solifenacin for overactive bladder in children.

Authors:  Stéphane Bolduc; Katherine Moore; Geneviève Nadeau; Sylvie Lebel; Pascale Lamontagne; Micheline Hamel
Journal:  J Urol       Date:  2010-08-21       Impact factor: 7.450

2.  Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study.

Authors:  Geneviève Nadeau; Annette Schröder; Katherine Moore; Lucie Genois; Pascale Lamontagne; Micheline Hamel; Eve Pellerin; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.